We report an integrated analysis of the primary Case Report Form (CRF) data from these trials.
We utilized the data from these trials to compare with competing designs based on the response to selection.
The data from these trials, therefore, is too weak to use in forming a recommendation for treatment of CHB.
Data from these trials demonstrated the consistent performance of these lines, validating the effectiveness of SUB1 in conferring tolerance of submergence, independent of the genetic background of the recipient variety or the environment where it is grown.
Phase III clinical trials are ongoing in the US for specific agents, and the standard of care for the treatment of HAE will continue to evolve as data from these trials become available.
The data from these trials are used to investigate the potential impact of their implementation on cod, haddock and whiting stocks in the North Sea (including the Kattegat and Skagerrak).
Large, international collaborative efforts at designing and conducting studies to optimize treatment options for patients with ErbB2-positive breast cancer are ongoing, and careful review of data from these trials will improve tailoring of these modern therapeutic strategies.
This review discusses the different designs of the primary adjuvant, switching, extended adjuvant, and sequencing trials that are investigating the use of AIs in the adjuvant treatment of breast cancer and provides direction regarding how the data from these trials could be used to guide treatment choice.
If individual participant data from these trials were to be combined, a meta-analysis of the resulting data, totaling approximately 2,300 patients, would allow estimation across a number of trials of the treatment effects both of ARB therapy and of β-blockade.
However, the analysis of cost data from these trials has received little attention to date.
The HDL-C data from these trials are summarized in Table 1.
